# AstraZeneca generated $15.29 billion in revenue compared with $13.59 billion in the year-earlier period.

*biotech · news · 2026-04-29 · MarketScreener*

## Key points

- AstraZeneca's first-quarter revenue surpassed analyst expectations, reaching $15.29 billion versus $14.94 billion forecasted.
- Oncology now represents about 44% of AstraZeneca’s total revenue and leads its late-stage pipeline.
- Sales of oncology and rare-disease drugs achieved double-digit growth during this quarter.
- AstraZeneca maintained its full-year guidance, expecting mid to high single-digit revenue growth.

**Companies:** AstraZeneca
**Countries:** United Kingdom

[Read the full story on MarketScreener](https://www.marketscreener.com/news/astrazeneca-gets-revenue-boost-from-cancer-drugs-ce7f59d3dd8df127)

---

Canonical: https://newsio.io/n/0d556bf5-d662-471a-a8fc-a7fa06f9f41c/astrazeneca-generated-15-29-billion-in-revenue-compared-with-13-59-billion-in-th
Summarized by Newsio from MarketScreener. https://newsio.io/how-it-works